Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Montana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Montana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Montana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Paris (NPI 1679561815)

Field	Value
Entity Type	Individual
Organization	Christopher Paris
Address	2820 Central Avenue
City	Billings
State	MT
ZIP	59102
Taxonomy	Specialist
NPI Enumerated	October 12, 2005

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

Practice is centered on intravitreal pharmacologic treatments and retina-focused procedures: the top Medicare revenue drivers are J2777 ($838.7K, 61.2%), J0178 ($323.4K, 23.6%), and 67028 ($82.3K, 6.0%), which together account for 90.9% of this provider's Medicare revenue. Those codes and their descriptions indicate the operation is primarily delivering injectable biologic therapy for retinal disease and performing isolated intravitreal injection procedures.

Medicare revenue scale is meaningful while Medicaid activity is absent: lifetime Medicare revenue is $1.4M and this provider has no Medicaid billing on file, so the entity should be treated as effectively single-payer (Medicare) from a claims-volume perspective. This concentration in a single public payer has implications for reimbursement exposure and network negotiations.

Revenue concentration is highly skewed toward a very small set of codes: the precomputed top-3 share is 90.9%, driven largely by a single J-code, J2777. Reliance on J2777 and J0178 for the bulk of revenue suggests revenue sensitivity to utilization and pricing of those specific retinal drugs.

J2777 shows very large absolute claim volume (28.9K claims) and substantial revenue ($838.7K) and is ranked #314 of 2039 providers nationally (85th percentile; typical, unremarkable volume for this code). While the rank places the provider above many peers nationally on J2777 activity, the dataset labels this as "typical, unremarkable volume," implying the activity level is consistent with many retinal injection practices rather than indicating market dominance.

Office visit volume for established patients is an outlier relative to national peers: 92012 has 1.2K claims and $73.6K in revenue (5.4% of Medicare revenue) and ranks #315 of 17177 providers nationally (98th percentile; extreme outlier, far above typical national volume for this code). This elevated established-patient evaluation volume suggests a sizeable ongoing follow-up population, consistent with chronic retina disease management.

Diagnostic imaging is a meaningful adjunct service: 92134 appears with 1.2K claims and $34K in revenue (2.5% of Medicare revenue) and ranks #1923 of 26868 providers nationally (93th percentile; typical, unremarkable volume for this code). The combination of high imaging and injection counts supports a care model that integrates OCT-based monitoring with therapeutic injections.

There is an observable preference toward branded biologic agents over compounded bevacizumab: J0178 (aflibercept) produced $323.4K (23.6%) across 464 claims and ranks #1995 of 3204 providers nationally (38th percentile; typical, unremarkable volume), whereas J9035 (bevacizumab) accounted for $15.6K (1.1%) across 273 claims and ranks #513 of 1852 providers nationally (72th percentile; typical, unremarkable volume). This mix indicates clinical or procurement patterns favoring higher-revenue branded agents in this practice.

Provider tenure is long-standing: the NPI was enumerated 2005-10-12 (~21 years ago), indicating an established presence in Billings, MT. Combined with the Medicare revenue profile and the code-specific ranks, the provider appears to be a mature, specialty-focused retinal/ophthalmology clinician with above-average injection and follow-up volumes nationally but not an outsized market dominator across all measured codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

7 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	28,920	$30	$838.7K
J0178	Injection, aflibercept, 1 mg	460	$700	$323.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	990	$80	$82.3K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,190	$60	$73.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,170	$30	$34K
J9035	Injection, bevacizumab, 10 mg	270	$60	$15.6K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	20	$100	$2K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 7 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Montana Distribution

Christopher Paris — 2 of 7 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Montana

Full comparison — all codes billed, vs. state median

7 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	20	460	$680	$663.4K
J2777	1	10	10,170	$30	$351.2K
67028	8	20	390	$90	$73.7K
92012	2	50	80	$60	$11.9K
J9035	3	10	100	$50	$10.3K
92134	10	160	100	$30	$7.8K
92004	125	150	40	$80	$4.4K

Nearby Providers

Other providers in the same ZIP code as Christopher Paris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Youth Dynamics, Inc.	MT	Mental Illness Community Based Residential Treatment Facility	$0	$65.4M
New Day, Inc.	MT	Mental Illness Community Based Residential Treatment Facility	$0	$27.7M
Youth Dynamics, Inc.	MT	Professional Counselor	$0	$24.6M
Resource, Support, & Development, Inc.	MT	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$21.3M
Brittany Curl	MT	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$17.5M
Rimrock Pediatric Dentistry	MT	Pediatric Dentistry	$0	$15.2M
Bridges Of Montana	MT	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$12.7M
The Childrens Clinic Of Billings, PC	MT	Pediatrics Physician	$0	$10.9M
Community Option Resource Enterprises, Inc.	MT	Developmentally Disabled Services Day Training Agency	$0	$9.8M
Ryan K. Larsen Dmd & Associates	MT	Dental Anesthesiology	$0	$8.3M

Christopher Paris — Billing Profile & Reimbursement Data

Sign up for Christopher Paris — Billing Profile & Reimbursement Data policy alerts

Christopher Paris — Billing Profile & Reimbursement Data

Sign up for Christopher Paris — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References